Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure FR-1984-1/2648 – measures in France
| Country | France , applies nationwide |
| Time period | Open ended, started on 01 January 1984 |
| Context | Restructuring Support Instruments |
| Type | Legislations or other statutory regulations |
| Category |
Supporting businesses to stay afloat
– Direct subsidies (full or partial) or damage compensation |
| Author | Frédéric Turlan (IRshare) and Eurofound |
| Measure added | 23 June 2022 (updated 04 December 2024) |
The research tax credit (RTC) aims to improve innovation and competitiveness of companies. Thanks to this tax credit, companies can incur research and development expenses and be partially reimbursed for these expenses. Far from being limited to large companies, the RTC is available to all industrial, commercial and agricultural companies, whatever their legal form and size, provided that they are taxed according to their actual regime and that they carry out research and/or development expenditure.
The R&D activities which can benefit from the regime are defined as:
The main categories of expenses which can give right to the tax credit are:
This research tax credit covers 30% of all R&D costs up to €100 million, and 5% above this threshold. As of 2013, innovation expenses incurred by SMEs are also eligible for the research tax credit (up to €80,000 of tax credit a year).
France’s research tax credit is also a powerful incentive for research partnerships, as all expenditure contracted out to public sector bodies is double-counted, thereby effectively doubling the research tax credit. Salaries paid to junior final-year doctoral and post-doctoral research personnel on their first permanent contract are quadruple-counted when calculating the research tax credit for two years.
The research tax credit and 'innovative new company' (JEI) schemes have been fixed for five years to provide businesses with visibility and legal security.
In 2018, the latest year for which estimated data is available, 28,800 companies declared expenditure under the CIR, i.e. almost 3 times their number in 2007 (9,886 declarants, one year before the 2008 reform) and almost 5 times their number in 2003 (5,833). The scheme generated a tax receivable of €7.25 billion in 2021.
According to the evaluation carried out by the National Commission for the Evaluation of Innovation Policies (CNEPI), in the report published in June 2021, the CIR:
| Workers | Businesses | Citizens |
|---|---|---|
| Does not apply to workers | Applies to all businesses | Does not apply to citizens |
| Actors | Funding |
|---|---|
|
National government
|
National funds
|
Social partners' role in designing the measure and form of involvement:
| Trade unions | Employers' organisations | |
|---|---|---|
| Role | No involvement | No involvement |
| Form | Not applicable | Not applicable |
Social partners' role in the implementation, monitoring and assessment phase:
None.
Unknown
Citation
Eurofound (2022), The research tax credit, measure FR-1984-1/2648 (measures in France), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/FR-1984-1_2648.html
Share
Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.